Technology

Odonate Therapeutics

$19.41
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.58 (-2.90%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ODT and other stocks, options, and ETFs commission-free!

About ODT

Odonate Therapeutics, Inc. Common Stock, also called Odonate Therapeutics, is a pharmaceutical company, which engages in the development of therapeutics that improves and extends the lives of patients with cancer. It focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The company was founded in March 2013 and is headquartered in San Diego, CA. The listed name for ODT is Odonate Therapeutics, Inc. Common Stock.

CEO
Kevin C. Tang
Employees
152
Headquarters
San Diego, California
Founded
2013
Market Cap
745.27M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
812.51K
High Today
$20.36
Low Today
$19.13
Open Price
$20.07
Volume
392.56K
52 Week High
$46.50
52 Week Low
$12.56

Collections

ODT Earnings

-$1.15
-$0.77
-$0.38
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 18, Pre-Market

You May Also Like

ALCO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure